journal article·2026-01Open access

A global thermodynamic-kinetic model capturing the hallmarks of liquid-liquid phase separation and amyloid aggregation

Kamal Bhandari, Yunxiang Sun, Huayuan Tang, Pu Chun Ke, Feng Ding

Cell Reports Physical Science· Volume 7· Issue 1

Abstract

Amyloid aggregation is associated with numerous neurodegenerative, systemic, and metabolic diseases. Amyloidogenic proteins often undergo liquid-liquid phase separation (LLPS), but the effects of LLPS on amyloid aggregation remain unclear, as contrasting fibrillization promotion and inhibition and even biphasic effects have been reported. Here, we adopt the phase-transition theory and integrate LLPS-induced heterogeneity of protein concentrations into a thermodynamic-kinetic model of aggregation. Oligomerization and fibrillization can occur both in the protein-rich condensates and the protein-poor solution. This model allows us to derive the time evolution of different states-monomers, condensates, oligomers, and fibrils-spanning a wide concentration range, and to determine how parameters governing LLPS, fibrillization, and oligomerization influence fibrillization kinetics, thereby capturing the contrasting features of LLPS driven by either monomers or oligomers. In sum, this global model reconciles the seemingly contradictory effects of LLPS on fibrillization and advances our understanding, modulation, and potential mitigation of pathological aggregation in amyloid diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · Alzheimer's disease research and treatments · Block Copolymer Self-Assembly

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (85)

Show source-provided references
1. Parkinson’s disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies10.1038/nrn3549 ↗
2. Amyloid beta: structure, biology and structure-based therapeutic development10.1038/aps.2017.28 ↗
3. Mechanisms of secretion and spreading of pathological tau protein10.1007/s00018-019-03349-1 ↗
4. Protein aggregation diseases: pathogenicity and therapeutic perspectives10.1038/nrd3050 ↗
5. Protein aggregation and neurodegenerative disease10.1038/nm1066 ↗
6. The amyloid hypothesis of Alzheimer’s disease at 25 years10.15252/emmm.201606210 ↗
7. Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy10.1038/s41422-018-0075-x ↗
8. Cryo-EM structure and inhibitor design of human IAPP (amylin) fibrils10.1038/s41594-020-0435-3 ↗
9. Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue10.1038/s41467-019-12683-8 ↗
10. Cryo-EM structure of an amyloid fibril formed by full-length human prion protein10.1038/s41594-020-0441-5 ↗
11. A new era for understanding amyloid structures and disease10.1038/s41580-018-0060-8 ↗
12. Common core structure of amyloid fibrils by synchrotron X-ray diffraction 1 1Edited10.1006/jmbi.1997.1348 ↗
13. Kinetics and thermodynamics of amyloid formation from direct measurements of fluctuations in fibril mass10.1073/pnas.0610659104 ↗
14. Distinct oligomerization and fibrillization dynamics of amyloid core sequences of amyloid-beta and islet amyloid polypeptide10.1039/C7CP05695H ↗
15. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism10.1073/pnas.1218402110 ↗
16. Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides10.1073/pnas.1401564111 ↗
17. Fibril structures of diabetes-related amylin variants reveal a basis for surface-templated assembly10.1038/s41594-020-0496-3 ↗
18. Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-β fibrils10.1038/s41594-020-0442-4 ↗
19. Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence?10.1007/s00125-010-1671-6 ↗
20. Aβ Oligomers – a decade of discovery10.1111/j.1471-4159.2006.04426.x ↗
21. Emerging biophysical origins and pathogenic implications of amyloid oligomers10.1038/s41467-025-58335-y ↗
22. Phase separation in biology10.1016/j.cub.2017.08.069 ↗
23. Polymer physics of intracellular phase transitions10.1038/nphys3532 ↗
24. Compositional Control of Phase-Separated Cellular Bodies10.1016/j.cell.2016.06.010 ↗
25. Liquid phase condensation in cell physiology and disease10.1126/science.aaf4382 ↗
26. Intrinsically disordered linkers determine the interplay between phase separation and gelation in multivalent proteins10.7554/eLife.30294 ↗
27. Developments in describing equilibrium phase transitions of multivalent associative macromolecules10.1016/j.sbi.2023.102540 ↗
28. How Hierarchical Interactions Make Membraneless Organelles Tick Like Clockwork10.1016/j.tibs.2020.12.011 ↗
29. Protein Network Structure Enables Switching between Liquid and Gel States10.1021/jacs.9b10066 ↗
30. Structure–Function Properties in Disordered Condensates10.1021/acs.jpcb.0c11057 ↗
31. Liquid–liquid phase separation of amyloid-β oligomers modulates amyloid fibrils formation10.1016/j.jbc.2023.102926 ↗
32. α-Synuclein aggregation nucleates through liquid–liquid phase separation10.1038/s41557-020-0465-9 ↗
33. Liquid–liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau10.1038/s41467-017-00480-0 ↗
34. Liquid-liquid phase separation induces pathogenic tau conformations in vitro10.1038/s41467-020-16580-3 ↗
35. Liquid–liquid phase separation of type II diabetes-associated IAPP initiates hydrogelation and aggregation10.1073/pnas.1916716117 ↗
36. Amyloid Aggregation under the Lens of Liquid–Liquid Phase Separation10.1021/acs.jpclett.0c02567 ↗
37. From a Droplet to a Fibril and from a Fibril to a Droplet: Intertwined Transition Pathways in Highly Dynamic Enzyme-Modulated Peptide-Adenosine Triphosphate Systems10.1021/jacs.3c13152 ↗
38. The role of liquid–liquid phase separation in aggregation of the TDP-43 low-complexity domain10.1074/jbc.RA118.007222 ↗
39. Dynamic arrest and aging of biomolecular condensates are modulated by low-complexity domains, RNA and biochemical activity10.1038/s41467-022-30521-2 ↗
40. Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization10.1016/j.cell.2015.09.015 ↗
41. Matter over mind: Liquid phase separation and neurodegeneration10.1074/jbc.REV118.001188 ↗
42. Formation and Maturation of Phase-Separated Liquid Droplets by RNA-Binding Proteins10.1016/j.molcel.2015.08.018 ↗
43. Watching liquid droplets of TDP-43CTD age by Raman spectroscopy10.1016/j.jbc.2021.101528 ↗
44. Sequestration within biomolecular condensates inhibits Aβ-42 amyloid formation10.1039/D0SC04395H ↗
45. Biomolecular condensates can both accelerate and suppress aggregation of α-synuclein10.1126/sciadv.abq6495 ↗
46. Myricetin Inhibits α-Synuclein Amyloid Aggregation by Delaying the Liquid-to-Solid Phase Transition10.1002/cbic.202200216 ↗
47. Phase Separation and Aggregation of α-Synuclein Diverge at Different Salt Conditions
48. Ōsawa · 1975
49. Molecular mechanisms of protein aggregation from global fitting of kinetic models10.1038/nprot.2016.010 ↗
50. The Kinetics of Nucleated Polymerizations at High Concentrations: Amyloid Fibril Formation Near and Above the “Supercritical Concentration.”10.1529/biophysj.105.073767 ↗
51. A Free Energy Barrier Caused by the Refolding of an Oligomeric Intermediate Controls the Lag Time of Amyloid Formation by hIAPP10.1021/jacs.7b08830 ↗
52. Kinetics of spontaneous filament nucleation via oligomers: Insights from theory and simulation10.1063/1.4965040 ↗
53. An Analytical Solution to the Kinetics of Breakable Filament Assembly10.1126/science.1178250 ↗
54. Amyloid-β forms fibrils by nucleated conformational conversion of oligomers10.1038/nchembio.624 ↗
55. Amyloid formation as a protein phase transition10.1038/s42254-023-00598-9 ↗
56. Amyloid Aggregation and Liquid–Liquid Phase Separation from the Perspective of Phase Transitions10.1021/acs.jpcb.3c01426 ↗
57. Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time10.1074/jbc.M117.791236 ↗
58. The amyloid state and its association with protein misfolding diseases10.1038/nrm3810 ↗
59. Thermodynamics of High Polymer Solutions10.1063/1.1723621 ↗
60. Solutions of Long Chain Compounds10.1063/1.1750930 ↗
61. [17] Analysis of protein aggregation kinetics10.1016/S0076-6879(99)09019-9 ↗
62. Thermodynamics of the Polymerization of Protein10.1042/bst0041168 ↗
63. Recent progress on understanding the mechanisms of amyloid nucleation10.1007/s12551-017-0353-8 ↗
64. Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly10.1073/pnas.0711664105 ↗
65. Competition between Intramolecular and Intermolecular Interactions in an Amyloid-Forming Protein10.1016/j.jmb.2009.04.042 ↗
66. Dehydration entropy drives liquid-liquid phase separation by molecular crowding10.1038/s42004-020-0328-8 ↗
67. TDP-43 Amyloid Fibril Formation via Phase Separation-Related and -Unrelated Pathways
68. Macromolecular crowding modulates α-synuclein amyloid fiber growth10.1016/j.bpj.2021.06.032 ↗
69. The effect of macromolecular crowding on protein aggregation and amyloid fibril formation10.1002/jmr.699 ↗
70. Effect of Different Salt Ions on the Propensity of Aggregation and on the Structure of Alzheimer’s Aβ(1-40) Amyloid Fibrils10.1016/j.jmb.2007.08.068 ↗
71. BRICHOS Domains Efficiently Delay Fibrillation of Amyloid β-Peptide10.1074/jbc.M112.393157 ↗
72. TIA1 regulates the generation and response to toxic tau oligomers10.1007/s00401-018-1937-5 ↗
73. Clusterin protects neurons against intracellular proteotoxicity10.1186/s40478-017-0481-1 ↗
74. FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions10.1016/j.cell.2018.03.056 ↗
75. Beyond aggregation: Pathological phase transitions in neurodegenerative disease10.1126/science.abb8032 ↗
76. Chaperone-Mediated Heterotypic Phase Separation Prevents the Amyloid Formation of the Pathological Y145Stop Prion Protein Variant10.1016/j.jmb.2025.168955 ↗
77. Regulation of physiological and pathological condensates by molecular chaperones
78. Star Polymers Reduce Islet Amyloid Polypeptide Toxicity via Accelerated Amyloid Aggregation10.1021/acs.biomac.7b01301 ↗
79. Metal ions affect the formation and stability of amyloid β aggregates at multiple length scales10.1039/C7CP05072K ↗
80. pH Dependence of Amyloid-β Fibril Assembly Kinetics: Unravelling the Microscopic Molecular Processes10.1002/anie.202210675 ↗
81. Secondary nucleation in amyloid formation10.1039/C8CC02204F ↗
82. Secondary nucleation of monomers on fibril surface dominates α -synuclein aggregation and provides autocatalytic amyloid amplification10.1017/S0033583516000172 ↗
83. Phase-separating RNA-binding proteins form heterogeneous distributions of clusters in subsaturated solutions10.1073/pnas.2202222119 ↗
84. Detecting and Tracking β-Amyloid Oligomeric Forms and Dynamics In Vitro by a High-Sensitivity Fluorescent-Based Assay10.1021/acschemneuro.4c00312 ↗
85. Nonclassical nucleation pathways in protein crystallization10.1088/1361-648X/aa8253 ↗